Lower riskMedical device recall · FDA · Published January 13, 2020
Mindray DP-30 Ultrasound: Incorrect Needle Guide Bracket in 65EC10EA Transducer
Mindray recalls DP-30 ultrasound systems with 65EC10EA transducers that may display incorrect needle-guide brackets. This could affect imaging accuracy during medical exams.
“Mindray DP-30 Ultrasound: Incorrect Needle Guide Bracket in 65EC10EA Transducer.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/66062-mindray-dp-30-ultrasound-incorrect-needle-guide-bracket-in-65ec10ea. Based on FDA recall #Z-1330-2020 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1330-2020%22&limit=1).
Mindray DS USA, Inc. dba Mindray North America recalled the DP-30 Digital Ultrasonic Diagnostic Imaging System on Jan. 13, 2020, according to the FDA. The device displays an incorrect needle-guide bracket when used with a specific transducer.
How to tell if you have it
Brand: Mindray
Product: DP-30 Digital Ultrasonic Diagnostic Imaging System
Part No.: 1155E-PA00004
Software versions: 03.00.00 and 03.01.00
The hazard
The DP-30 displays an incorrect needle-guide bracket when used with the 65EC10EA model transducer.
Context
GovInfoNow's records show Mindray DS USA, Inc. dba Mindray North America has 13 other recalls on record since July 14, 2017. Other recent recalls of similar products include Mindray BeneVision Distributed Monitoring (Nov. 18, 2025), Mindray Isoflurane V90 Vaporizer (Oct. 20, 2025), and Mindray BeneVision N1 Patient Monitor (Aug. 15, 2025). Other recent recalls of similar products include DeRoyal Myocardial Probe (Aug. 20, 2026).
How to tell if you have this one
Check if your DP-30 system has software version 03.00.00 or 03.01.00 and is used with the 65EC10EA transducer. The product was sold for adult, pregnant, pediatric, and neonatal imaging exams.
Brand
Mindray
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Check Software Version
Verify your DP-30 system's software version is 03.00.00 or 03.01.00.
Where it went and when
Where it was distributed
Distributed nationwide; the notice names 7 states.
Named in the notice
Covered by “nationwide”
Not listed
FDA distribution: “US Nationwide distribution in the states of CA, GA, IL, MD, NY, SC, and WA.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: California, Georgia, Illinois, Maryland, New York, South Carolina, Washington.
Recall timeline
FDA terminated this recall 7 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-1330-2020 (January 13, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1330-2020 to see it in context.
Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.